US Patent 8,852,110 granted to DVX, LLC and licensed exclusively by Arterium Medical, LLC. This patent describes how to make a thin film of piezopolymer material generate a focused beam of ultrasound energy. Arterium Medical believes that this patent limits others from making a flexible thin film generate an ultrasound beam. A usable bio-sensor must […]
Arterium Medical, LLC is incorporated in Delaware with an engineering facility in Princeton, NJ. The facility is co-located with DVX, LLC who is our technology partner and licensor.
Boston: NHLBI sponsors John Turner to present DVX’s technology and commercialization opportunities to investors and industry partners.
The claimed invention improves the performance of an ultrasound piezopolymer transducer by incorporating an appropriate matching layer deposited on the substrate. The patent is granted to DVX, LLC and licensed exclusively by Arterium Medical. This patent with know-how allows Arterium to make co-polymer ultrasound sensors that are more efficient than previously possible.
NIH supports John Turner to attend LARTA training to develop a commercialization strategy for DVX’s technology. John Turner presents product opportunities to investors in Los Angeles and Washington, DC.
The claimed invention of an “Angle-Independent Doppler System for Screening” is a fundamental patent on multiple ultrasound receivers with known phase relationship used to make the ultrasound beam pattern more focused. The patent is granted to DVX, LLC and exclusively licensed to Arterium Medical. The co-polymer thin film sensor uses this technique.